Developing the science base for reducing tobacco harm
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The University of Minnesota Transdisciplinary Tobacco Use Research Center has been examining the multiple dimensions and the scientific evidence required to determine the feasibility of tobacco harm reduction as a means to reduce tobacco-related mortality and morbidity. Because of the complexity associated with exploring this area, an interdisciplinary approach is necessary. The research components that have been of particular focus at our center include (a) developing and validating biomarkers of tobacco-related exposure and toxicity, (b) developing animal models and designing studies with humans to assess a variety of smoking reduction approaches and potential reduced exposure products, and (c) determining individual differences in response to these interventions and products. A description of the ongoing activities and challenges in these areas is provided, along with projected directions for the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metabolism and Disposition Kinetics of Nicotine
Hukkanen, J., Jacob, P., & Benowitz, N. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.3 · Cited by 1,818
Effect of smokeless tobacco (snus) on smoking and public health in Sweden
Foulds, J., Ramstrom, L., Burke, M., & Fagerström, K. (2003) · Tobacco Control · doi:10.1136/tc.12.4.349 · Cited by 471
Smoking Cessation and Time Course of Decreased Risks of Coronary Heart Disease in Middle-Aged Women
Kawachi, I. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420020075009 · Cited by 264
Does smoking reduction increase future cessation and decrease disease risk? A qualitative review
Hughes, J., & Carpenter, M. (2006) · Nicotine & Tobacco Research · doi:10.1080/14622200600789726 · Cited by 238
Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers
Benowitz, N. L., & Jacob III, P. (1993) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1993.27 · Cited by 232
Godtfredsen, N. S. (2002) · Thorax · doi:10.1136/thorax.57.11.967 · Cited by 203
The feasibility of smoking reduction: an update
Hughes, J. R., & Carpenter, M. J. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01174.x · Cited by 168 · cited 2×
“…smoking reduction studies have shown greater reductions in smoking with the use of medicinal nicotine compared with placebo or no-treatment groups, but again no dramatic reductions in exposure biomarkers were observed as a result of using these treatments (see Hughes & Carpenter, 2005, for review).”
BackgroundGodtfredsen, N. S., Osler, M., Vestbo, J., Andersen, I., & Prescott, E. (2003) · Journal of Epidemiology and Community Health · doi:10.1136/jech.57.6.412 · Cited by 112 · cited 2×
“, 2005) and that, although persistent light smokers experienced fewer myocardial infarction and hospitalization for COPD, as previously noted reducers did not (Godtfredsen et al., 2003; Godtfredsen, Vestbo et al., 2002).”
BackgroundSuppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine
Benowitz, N. L., Zevin, S., & Jacob, P. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37887-5 · Cited by 108
Effects of cigarette reduction on cardiovascular risk factors and subjective measures
Hatsukami, D. K., Kotlyar, M., Allen, S., Jensen, J., Li, S., Le, C., & Murphy, S. (2005) · Chest · doi:10.1378/chest.128.4.2528 · Cited by 79 · cited 1×
“Hatsukami et al. (2005) found that among smokers who reduced their smoking by a mean of about 70% (from 24 to 7 cigarettes/day), significant improvements in biomarkers for cardiovascular disease, such as white blood cell count, cholesterol concentrations, blood pressure, and heart rate were present.”
BackgroundSelf-citation
Cited by
Hazardous Compounds in Tobacco Smoke
Talhout, R., Schulz, T., Florek, E., Van Benthem, J., Wester, P., & Opperhuizen, A. (2011) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph8020613 · Cited by 829
Piano, M. R., Benowitz, N. L., FitzGerald, G. A., Corbridge, S., Heath, J., Hahn, E., Pechacek, T. F., Howard, G., & on behalf of the American Heart Association Council on Cardiovascular Nursing (2010) · Circulation · doi:10.1161/cir.0b013e3181f432c3 · Cited by 246
“117,129 The debate relates to (1) the observational nature of data supporting ST or PREP for smoking cessation; (2) ethical issues associated with the concept of harm reduction; (3) the possibility that ST use may provide a “gateway” for the initiation of smoking; (4) the possibility that ST use will result in fewer s…”
BackgroundDoes nicotine replacement therapy cause cancer? Evidence from the Lung Health Study
Murray, R. P., Connett, J. E., & Zapawa, L. M. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp104 · Cited by 93
Gene expression profiles associated with cigarette smoking and moist snuff consumption
Arimilli, S., Madahian, B., Chen, P., Marano, K., & Prasad, G. L. (2017) · BMC Genomics · doi:10.1186/s12864-017-3565-1 · Cited by 41
Liu, J., Rensch, J., Wang, J., Jin, X., Vansickel, A., Edmiston, J., & Sarkar, M. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06172-y · Cited by 37
Metadata
- Authors
- Hatsukami, D., Joseph, A., LeSage, M., Jensen, J., Murphy, S., Pentel, P., Kotlyar, M., Borgida, E., Le, C., & Hecht, S.
- Venue
- Nicotine & Tobacco Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-11
- Volume
- 9
- Pages
- 537-553
- ISSN
- 1462-2203 (ISSN-L)
- OpenAlex
- W2124233383
- Cited by
- 70
- References
- 11
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.